Obesity is associated with an increased risk of at least thirteen cancers and with negative cancer outcomes including increased metastasis, impaired response to therapy, elevated risk of recurrence, and an increase in cancer-related mortality 2,3,4,5
The effect tends to be dose-dependent and most intense during early treatment or when doses increase
Compounded formulations are not FDA-reviewed
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barretts esophagus
Diarrhea specifically affected 9% to 20% of participants across dose groups in Phase 2
It was mostly on my jawline and it was sometimes cystic, sometimes patches of whiteheads, but always annoying and ugly